Malignant neoplasms in renal transplant patients: a 24-year experience.
Bordes-Aznar
J
J
Department of Transplants, Instituto Nacional de la Nutrición Salvador Zubirán, Mexico D.F.
Mancilla
E
E
Rosenblum
M
M
Gabilondo
F
F
Orozco
R
R
Angeles
A
A
Alberú
J
J
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008800:Mexico; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies
D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone